Palladium-based alloys for use in the body and suitable for MRI imaging
Ultra-low magnetic susceptibility, biocompatible palladium-tin, palladium-aluminum, and palladium-tantalum alloys include at least 75 at % palladium, between about 3 and 20 at % tin, aluminum, or tantalum, respectively, and one or more other additives chosen from niobium, tungsten, molybdenum, zirconium, titanium, tin for non-palladium-tin alloys, aluminum for non-palladium-aluminum alloys, or tantalum for non-palladium-tantalum alloys, up to about 22 at % total.
1. A palladium-tin ternary or higher alloy consisting of:
a. at least 75 at % palladium;
b. between about 5 and 20 at % tin; and
c. one or more additives chosen from: aluminum, tantalum, niobium, tungsten, molybdenum, and titanium, in an amount of at least 5 at % total and up to about 20 at % total, wherein the palladium-tin ternary or higher alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs), and wherein the palladium-tin alloy is biocompatible.
2. The alloy of claim 1 , wherein the one or more additives is up to 10 at % total.
3. The alloy of claim 1 , wherein the alloy forms at least a portion of a medical device.
4. The alloy of claim 3 , wherein the medical device comprises an electrically active medical device.
5. A palladium-aluminum ternary or higher alloy, consisting of:
a. at least 75 at % palladium;
b. between 5 and 20 at % aluminum; and
c. one or more additives chosen from: tin, tantalum, or titanium, up to 20 at % total, wherein the palladium-aluminum ternary or higher alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs) and is biocompatible.
6. The alloy of claim 5 , wherein the one or more additives is up to 10 at % total.
7. The alloy of claim 5 , wherein the alloy forms at least a portion of a medical device.
8. The alloy of claim 7 , wherein the medical device comprises an electrically active medical device.
9. A palladium-tantalum ternary or higher alloy, consisting of:
a. at least 75 at % palladium;
b. between 10 and 20 at % tantalum; and
c. a balance of the palladium-tantalum ternary or higher alloy including one or more additives chosen from: tin, aluminum or niobium wherein the palladium-tantalum ternary or higher alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs) and is biocompatible.
10. The alloy of claim 9 , wherein the one or more additives is up to 10 at % total.
11. The alloy of claim 9 , wherein the alloy forms at least a portion of a medical device.
12. The alloy of claim 11 , wherein the medical device comprises an electrically active medical device.
13. A palladium alloy, consisting of:
a. at least 75 at % palladium;
b. a minimum of 5 at % aluminum;
c. a minimum of 5 at % tin; and
d. a minimum of 5 at % tantalum,
wherein the palladium alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs), and wherein the palladium alloy is biocompatible.
14. The alloy of claim 13 , wherein the alloying additions are up to 15 at % total.
15. The alloy of claim 13 , wherein the alloy forms at least a portion of a medical device.
16. The alloy of claim 15 , wherein the medical device comprises an electrically active medical device.
17. An electrically active medical device, consisting of:
a palladium ternary or higher alloy comprising:
at least 75 at % palladium; and
two to four additions of tin, aluminum, tantalum, niobium, tungsten, molybdenum, zirconium and titanium totaling between about 15 and 25 at %, wherein at least one of the additions includes tin, aluminum or tantalum, and
wherein the portion of the electrically active medical device formed of the palladium ternary or higher alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs) and is biocompatible.
18. The medical device of 17 , wherein the electrically active medical device comprises one or more of: a neuro-stimulation electrode, a cardiac pacing electrode, and a cardiac defibrillation shock coil.
19. An electrically passive medical device, consisting of:
a palladium ternary or higher alloy comprising:
at least 75 at % palladium; and
two to four additions of tin, aluminum, tantalum, niobium, tungsten, molybdenum, zirconium and titanium totaling between about 15 and 25 at %, wherein at least one of the additions includes tin, aluminum or tantalum in an amount of at least 2.5 at % total, and
wherein the portion of the electrically passive medical device formed of the palladium ternary or higher alloy has an ultra-low magnetic susceptibility with a volumetric magnetic susceptibility at or below 3×10-6 (cgs) and is biocompatible.
20. The medical device of 19 , wherein the electrically passive medical device comprises one or more of: an embolic coil, a guide wire, a vena cava filter, a suture, a staple, and a clip.
21. The alloy of claim 3 , wherein the medical device comprises an electrically passive medical device.
22. The alloy of claim 7 , wherein the medical device comprises an electrically passive medical device.
23. The alloy of claim 11 , wherein the medical device comprises an electrically passive medical device.
24. The alloy of claim 4 , wherein the electrically active medical device comprises one or more of: a neuro-stimulation electrode, a cardiac pacing electrode, and a cardiac defibrillation shock coil.
25. The alloy of claim 8 , wherein the electrically active medical device comprises one or more of: a neuro-stimulation electrode, a cardiac pacing electrode, and a cardiac defibrillation shock coil.
26. The alloy of claim 12 , wherein the electrically active medical device comprises one or more of: a neuro-stimulation electrode, a cardiac pacing electrode, and a cardiac defibrillation shock coil.